23023-08-7

Basic information

• Product Name: 1,2-dimethoxy-4-(2-nitrobut-1-en-1-yl)benzene
• CAS NO: 23023-08-7
• Molecular Formula: C₁₂H₁₅NO₄
• Molecular Weight: 237.2518
• Mol File: 23023-08-7.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 362.5°C at 760 mmHg
• Flash Point: 154°C
• Density: 1.143g/cm³
• Vapor Pressure: 4.03E-05mmHg at 25°C
• Refractive Index: 1.548
• CAS DataBase Reference: 1,2-dimethoxy-4-(2-nitrobut-1-en-1-yl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-dimethoxy-4-(2-nitrobut-1-en-1-yl)benzene(23023-08-7)
• EPA Substance Registry System: 1,2-dimethoxy-4-(2-nitrobut-1-en-1-yl)benzene(23023-08-7)

Safety Data

• Hazardous Substances Data: 23023-08-7(Hazardous Substances Data)

Usage

Usage

Synthesis of pharmaceuticals and organic compounds

Structural components

Two methoxy groups
A nitro group
A butenyl group attached to a benzene ring

Color

Yellow

Solubility

Insoluble in water, soluble in organic solvents

Hazardous nature

Potentially hazardous compound

Safety precautions

Can cause irritation to skin, eyes, and respiratory system upon exposure; should be handled with care

Upstream product

• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 108-03-2 1-Nitropropane 

Downstream Products

• 55174-55-5 2-amino-1-(3,4-dimethoxyphenyl)butane 
• 123312-29-8 2-(2-Bromo-5-methoxy-phenyl)-N-[1-(3,4-dimethoxy-benzyl)-propyl]-acetamide 
• 123312-34-5 1-(2-Bromo-5-methoxy-benzyl)-3-ethyl-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline 

Relevant articles and documents

Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds.

NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5, R6, X and Y are as described in the description and in the claims, as well as or pharmaceutically acceptable salts, or enantiomers, or diastereomers thereof. The invention also contains compositions including the compounds and methods of using the compounds.